Shortly after acquiring Elektrofi to beef up its subcutaneous drug-delivery offerings, Halozyme Therapeutics has struck ...
COLORADO SPRINGS, CO, UNITED STATES, January 14, 2026 /EINPresswire.com/ -- Lahjavida Bio, a biotechnology company ...
The Surf Bio acquisition comes shortly after Halozyme bought another company with a subcutaneous delivery technology, ...
In an unlikely collaboration between Skoltech's Petroleum Center and the drug delivery team from the Institute's Neuro Center ...
In a study published in the Journal of Extracellular Vesicles, scientists from the UF Health Cancer Institute have found a way to make treatment for a notoriously aggressive breast cancer more ...
Optimizing drug delivery to the lymphatic system is essential for effective cancer treatment, as lymph node (LN) metastasis ...
In a merger between two subcutaneous drug delivery companies, Halozyme Therapeutics is paying $750 million in cash to acquire Elektrofi. Aside from the $750 million upfront payment, the deal also ...
Defence Therapeutics Inc., (CSE: DTC) (FSE: DTC) (OTCQB: DTCFF) ("Defence" or the "Company"), a publicly traded biotechnology company, today announced an evolution of its corporate positioning to ...
Delivering therapies to the brain remains a major challenge due to the limited permeability of the blood-brain barrier. In a ...
News-Medical.Net on MSN
Microneedle patches enhance acne treatment with dual drug delivery
Acne vulgaris affects a large proportion of adolescents and young adults and can lead to long-term scarring and psychological distress. Its pathogenesis involves excessive sebum production, bacterial ...
A project that began as a Gates Foundation-funded effort to expand contraceptive options, particularly in developing nations, has led to the development of a new method to deliver certain drugs in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results